CompoAtlas

OmegCal

Natural health product licensed in Canada

Other names
7030 OmegCal, Natür 7030 OmegCal, Natür OmegCal
Licence holder
Nutrican, Inc.
NPN or DIN-HM
80085157
Status
Active licence
Licence date
11 May 2018
Revision date
6 December 2022
Form
Capsule, molle
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Lécithine

Source : Lecithin

15 mgNot calculated
Calcium

Source : Hyriopsis cumingii - Pearl

250 mg500,000 µg
Calcium

Source : Pteria martensii - Pearl

250 mg500,000 µg
Huile de phoque

Source : Pagophilus groenlandicus - petit lard

Potency : 3 % Docosapentaenoic acid

650 mgNot calculated
Vitamine D

Source : Cholécalciférol

2 mcg4 µg

Non-medicinal ingredients

Gélatine, Glycérine, Saveur, Cire d'abeille jaune, Huile de fève de soja, Eau purifiée

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 years2 Capsule1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

A factor in the maintenance of good health. Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may help prevent bone loss/osteoporosis (in peri- and postmenopausal women) (in later life). Helps in the development and maintenance of bones and teeth especially in childhood, adolescence and young adulthood. Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may reduce the risk of developing osteoporosis (in peri- and postmenopausal women) (in later life). Helps in the development and maintenance of bones and teeth. Source of omega-3 fatty acids for the maintenance of good health. Source of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and docosapentaenoic acid (DPA) for the maintenance of good health. Helps in the absorption and use of calcium and phosphorus. Calcium intake, when combined with sufficient Vitamin D, a healthy diet and regular exercise may reduce the risk of developing osteoporosis.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80085157

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging

List recorded in 2022. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line